A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionre7a2lc9jmg9d3c2tq21qgo5cuk4nvr6): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

Primary Renal Carcinoid Tumor: Report of Two Cases. | LitMetric

Introduction: Primary renal carcinoid tumors are a rare subset of neuroendocrine tumors arising in the kidneys. Although carcinoid syndrome has occasionally been described, most patients are asymptomatic at presentation.

Case Presentations: We present 2 cases of primary renal carcinoid tumor and describe the workup, immunohistochemical analysis, treatment, and surveillance of each female patient. The first patient was found to have a renal mass on imaging during a workup of chronic abdominal pain and subsequently underwent a robotic radical nephrectomy. The second patient was found to have an incidental renal mass on imaging and subsequently underwent renal biopsy, followed by robot-assisted laparoscopic partial nephrectomy. In both cases, a gallium dotatate Ga 68-enhanced positron emission tomography/computed tomography scan was used to further assess disease burden.

Discussion: This report describes 2 cases of primary renal carcinoid tumor with unique presentations and management in our regional health care system. Because primary renal carcinoid tumors are quite uncommon, there are no clear established guidelines on preoperative imaging or posttreatment surveillance in patients with these tumors. There remains a large amount of variability in the diagnosis, workup, immunohistochemical analysis, treatment, and surveillance of patients with primary renal carcinoid tumors. As we learn more about this disease, we hope to optimize patient outcomes and standardize pretreatment workup and posttreatment surveillance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089591PMC
http://dx.doi.org/10.7812/TPP/19.147DOI Listing

Publication Analysis

Top Keywords

primary renal
24
renal carcinoid
24
carcinoid tumor
12
carcinoid tumors
12
renal
8
cases primary
8
workup immunohistochemical
8
immunohistochemical analysis
8
analysis treatment
8
treatment surveillance
8

Similar Publications

Stereotactic Radiation for Primary Renal Cell Carcinoma: Is It Ready for Prime Time?

Eur Urol Oncol

March 2025

Division of Urologic Oncology, Department of Urology, Faculty of Medicine, Istanbul University, Istanbul, Turkey. Electronic address:

View Article and Find Full Text PDF

Outcomes following inferior vena cava reconstruction at an advanced surgical unit.

Eur J Surg Oncol

March 2025

Faculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, NSW, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, NSW, Australia; RPA Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, NSW, Australia; Department of Hepatobiliary and Upper Gastrointestinal Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Department of Surgery, Chris O'Brien Lifehouse, Sydney, NSW, Australia. Electronic address:

Background: Inferior vena cava (IVC) resection and reconstruction is a viable option for managing complex intra-abdominal tumours. This study evaluates the impact of surgical approach to IVC reconstruction on early oncological, post-operative and short-term survival outcomes.

Methods: This retrospective cohort study included patients who underwent IVC reconstruction between January 2015 and June 2024 for any indication, at two tertiary referral hospitals in Sydney, Australia.

View Article and Find Full Text PDF

Advanced in vitro evaluation of drug-induced kidney injury using microphysiological systems in drug discovery and development.

Drug Metab Pharmacokinet

February 2025

Pharmacokinetics and Non-Clinical Safety Department, Nippon Boehringer Ingelheim Co., Ltd., Kobe, Japan.

Drug-induced kidney injury (DIKI) is a major cause of acute kidney injury (AKI). Given concerns about animal welfare and the need for more accurate prediction of human events, there is an urgent need to develop an in vitro evaluation method for DIKI using human cells. Renal proximal tubular epithelial cells (RPTECs) are the main targets of DIKI in drug discovery and development because of their abundant expression of drug transporters that contribute to renal-specific drug distribution.

View Article and Find Full Text PDF

Objective: This study aimed to comprehensively evaluate the performance of fluorine-18 fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) and investigate the association between metabolic parameters, programmed cell death ligand 1 (PD-L1) expression, and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma (FHRCC).

Methods: Twenty-nine patients with FHRCC were prospectively enrolled from May 2020 to February 2023 for F-FDG PET/CT. The maximum standardized uptake value (SUVmax), peak standardized uptake value (SUVpeak), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of primary/recurrent tumors were analyzed.

View Article and Find Full Text PDF

Combination therapy is a cornerstone of modern type 2 diabetes management, extending beyond traditional goals of glucose, blood pressure, and lipid control to focus on therapies protecting the heart and kidneys. The introduction of sodium-glucose cotransporter-2 inhibitors (SGLT2is), glucagon-like peptide receptor agonists (GLP-1RAs), and nonsteroidal mineralocorticoid receptor antagonists (nsMRAs) has reshaped clinical guidelines in recent decades. However, the effects of combining these drug classes remain uncertain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!